GREY:VDQSF - Post by User
Comment by
syienaon Oct 11, 2016 1:37pm
158 Views
Post# 25331455
RE:small NR on cse
RE:small NR on cseNice to get an update on Management.
VODIS ANNOUNCES C SUITE APPOINTMENTS & ADDITIONS October 11, 2016 – Vancouver, British Columbia – Vodis Pharmaceuticals Inc. (CSE: VP / FSE: 1JV) ("Vodis" or the "Company") is very pleased to announce that Ivan Miliovski who is one of the company's founders has moved from the interim CEO role to full time CEO position. Additionally Vodis is very pleased to announce the appointment of Mark Lotz as their CFO. Mr Lotz is a Chartered Professional Accountant practicing publicly through his firm Lotz CPA Inc. Having qualified in 1994 he brings a wealth of experience in business, tax and consulting. Formerly a CEO and CFO in the brokerage industry, he also has senior management experience in the mining, manufacturing and digital media sectors. He provides strategic tax and business planning and is a sought after expert for complex contractual issues and financial quantification. He regularly consults with legal firms acting as an expert witness on matters of securities regulation and litigation. He sits on the board of and is chair of the audit committees for a number of public companies. In addition he serves as the CFO of TrackX Holdings Inc., the Canadian parent of a U.S. based assets tracking solutions provider. "Mark is an excellent addition to our team and will provide a key analytical approach we need to develop and execute our business model. It's crucial as we expand our business that we grow with the bottom line in mind and we establish a clear picture of what true costs go into every dollar of revenue we can create." States CEO Ivan Miliovski. For further information, please contact: